ES2107174T3 - Derivados del etoposido, su procedimiento de preparacion, su utilizacion a titulo de medicamento y su utilizacion para la preparacion de un medicamento destinado al tratamiento anticanceroso. - Google Patents

Derivados del etoposido, su procedimiento de preparacion, su utilizacion a titulo de medicamento y su utilizacion para la preparacion de un medicamento destinado al tratamiento anticanceroso.

Info

Publication number
ES2107174T3
ES2107174T3 ES94902836T ES94902836T ES2107174T3 ES 2107174 T3 ES2107174 T3 ES 2107174T3 ES 94902836 T ES94902836 T ES 94902836T ES 94902836 T ES94902836 T ES 94902836T ES 2107174 T3 ES2107174 T3 ES 2107174T3
Authority
ES
Spain
Prior art keywords
preparation
ethoposide
derived
cancer treatment
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94902836T
Other languages
English (en)
Inventor
Jean-Pierre Seripharm Te Robin
Robert Kiss
Thierry Imbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of ES2107174T3 publication Critical patent/ES2107174T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN COMPUESTO DE FORMULA GENERAL (I) EN LA QUE R'' REPRESENTA UN ATOMO DE HIDROGENO O UN RADICAL R Y R REPRESENTA UN RESTO ACILO, Y SU PROCESO DE PREPARACION. SE REFIERE TAMBIEN A SU UTILIZACION COMO MEDICAMENTO, ASI COMO A LA PREPARACION DE UN MEDICAMENTO DESTINADO AL TRATAMIENTO ANTICANCEROSO. SE REFIERE POR FIN A UNA COMPOSICION FARMACEUTICA QUE LO COMPRENDE.
ES94902836T 1992-12-22 1993-12-20 Derivados del etoposido, su procedimiento de preparacion, su utilizacion a titulo de medicamento y su utilizacion para la preparacion de un medicamento destinado al tratamiento anticanceroso. Expired - Lifetime ES2107174T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9215460A FR2699535B1 (fr) 1992-12-22 1992-12-22 Dérivés de l'étoposide, leur procédé de préparation, leur utilisation à titre de médicament et leur utilisation pour la préparation d'un médicament destiné au traitement anticancéreux.

Publications (1)

Publication Number Publication Date
ES2107174T3 true ES2107174T3 (es) 1997-11-16

Family

ID=9436898

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94902836T Expired - Lifetime ES2107174T3 (es) 1992-12-22 1993-12-20 Derivados del etoposido, su procedimiento de preparacion, su utilizacion a titulo de medicamento y su utilizacion para la preparacion de un medicamento destinado al tratamiento anticanceroso.

Country Status (11)

Country Link
US (1) US5643885A (es)
EP (1) EP0675895B1 (es)
JP (1) JPH08504795A (es)
AT (1) ATE155791T1 (es)
CA (1) CA2152270A1 (es)
DE (1) DE69312512T2 (es)
DK (1) DK0675895T3 (es)
ES (1) ES2107174T3 (es)
FR (1) FR2699535B1 (es)
GR (1) GR3025050T3 (es)
WO (1) WO1994014829A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
FR2730233B1 (fr) * 1995-02-08 1997-04-25 Pf Medicament Derives triaryloxyacetyl d'epipodophyllotoxines, leur procede de preparation et leur utilisation comme medicaments anticancereux
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
CN107964014A (zh) * 2017-10-28 2018-04-27 兰州大学 一种邻硝基芳酰化衍生物类化合物、制备方法及其应用
WO2023092188A1 (en) * 2021-11-26 2023-06-01 DemAgtech Pty Ltd "compounds and methods"
CN115141208B (zh) * 2022-08-05 2024-03-08 贵州大学 一种含各类酯基结构的鬼臼毒素类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016043A (en) * 1978-03-08 1979-09-19 Danochemo As Bacteria-containing product for use in animal feeds, and its production
KR920006865B1 (ko) * 1984-05-18 1992-08-21 워싱톤 유니버시티 테크놀러지 어소우시에이츠 인코오퍼레이티드 입자나 액적을 피복하는 방법과 장치
US5066645A (en) * 1989-09-01 1991-11-19 Bristol-Myers Company Epipodophyllotoxin altroside derivatives
FR2658824B1 (fr) * 1990-02-27 1992-07-03 Pf Medicament Tris acetyl-2",3",4' ethylidene-4",6" beta-d-glucopyranosides, leur preparation et leur utilisation pour la preparation d'ethylidene beta-d-glucopyranoside de demethyl-4' epipodophyllotoxine.
CN1025918C (zh) * 1990-06-07 1994-09-14 国家医药管理局上海医药工业研究院 抗肿瘤药表鬼臼毒吡喃糖甙的合成新工艺

Also Published As

Publication number Publication date
FR2699535A1 (fr) 1994-06-24
EP0675895A1 (fr) 1995-10-11
ATE155791T1 (de) 1997-08-15
DE69312512T2 (de) 1998-03-05
US5643885A (en) 1997-07-01
EP0675895B1 (fr) 1997-07-23
CA2152270A1 (fr) 1994-07-07
GR3025050T3 (en) 1998-01-30
DE69312512D1 (de) 1997-09-04
FR2699535B1 (fr) 1995-03-17
DK0675895T3 (da) 1998-02-23
WO1994014829A1 (fr) 1994-07-07
JPH08504795A (ja) 1996-05-21

Similar Documents

Publication Publication Date Title
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
HU9602051D0 (en) Delta12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
IL124966A0 (en) 1-indanyl- and 1-indanylidene-acetic derivatives
ES2107174T3 (es) Derivados del etoposido, su procedimiento de preparacion, su utilizacion a titulo de medicamento y su utilizacion para la preparacion de un medicamento destinado al tratamiento anticanceroso.
ES2094638T3 (es) N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
TW261605B (es)
ES2095058T3 (es) Derivados del 3-azabiciclo(3.2.0)heptano substituidos como productos intermedios.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 675895

Country of ref document: ES